首页> 外文期刊>Therapeutic advances in medical oncology. >Author response to ‘Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA, et al. “Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study”’
【24h】

Author response to ‘Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA, et al. “Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study”’

机译:作者响应“与高度人工酮饮食相关的问题:编辑的信Re:Van der Louw Ejtm,Olieman JF,Van Den Bemt PMLA等。 “酮饮食治疗作为辅助标准治疗胶质母细胞瘤的标准治疗:一种可行性和安全研究”'

获取原文
       

摘要

We are pleased to submit a response to the Letterto the Editor you have received from Klementet al. on our study “Ketogenic diet treatment asadjuvant to standard treatment of glioblastomamultiforme: a feasibility and safety study.”1 Wethank them for their interest in our study. In theirletter, they comment that their major concern isthe prescription of a highly artificial ketogenicdiet (KD) over 6weeks that could have negativelyinfluenced the overall survival (OS) in our study.Regarding the OS, we agree that it was lower thanaverage reported results, but we expand furtheron this point. However, we disagree with many ofthe other points raised.
机译:我们很高兴地向您从Klementet al收到的编辑器提交回复。在我们的研究中,“酮饮食治疗Asadjuvant对Glioblastomamultifice的标准治疗:一种可行性和安全研究。”1为他们对我们研究的兴趣讨厌他们。在他们的意见中,他们评论称,他们的主要问题是一个高度人工酮酮(KD)的处方超过6周,可以在我们的研究中产生负面的生存(OS)。抛弃操作系统,我们同意它是较低的报告结果,但是我们展开了这一点。但是,我们不同意许多提出的其他观点。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号